For over a quarter-century, this actively managed fund has provided investors with an economical way to access a diverse range of companies operating within the global healthcare industry. Its holdings span various segments, including pharmaceutical developers, medical equipment manufacturers, and groundbreaking research institutions. Compared to other healthcare-focused funds, it generally boasts broader international exposure and tends to have a more stable portfolio with less frequent trading.